The dynamics of the establishment of, and reactivation from, gammaherpesvir
uses latency has not been quantitatively analyzed in the natural host. Gamm
aherpesvirus 68 (gamma HV68) is a murine gammaherpesvirus genetically relat
ed to primate gammaherpesviruses that establishes a latent infection in inf
ected mice. We used limiting dilution reactivation (frequency of cells reac
tivating gamma HV68 in vitro) and limiting dilution PCR (frequency of cells
carrying gamma HV68 genome) assays to compare gamma HV68 latency in normal
(C57BL/6) and B-cell-deficient (MuMT) mice. After intraperitoneal (i.p.) i
noculation, latent gamma HV68 was detected in the spleen, bone marrow, and
peritoneal cells, Both B-cell-deficient and C57BL/6 mice established latent
infection in peritoneal cells after either i.p. or intranasal (i.n.) inocu
lation. In contrast, establishment of splenic latency was less efficient in
B-cell-deficient than in C57BL/6 mice after i.n. inoculation. Analysis of
reactivation efficiency (reactivation frequency compared to frequency of ce
lls carrying gamma HV68 genome) revealed that (i) regardless of route or mo
use strain, splenic cells reactivated gamma HV68 less efficiently than peri
toneal cells, (ii) the frequency of cells carrying gamma HV68 genome was ge
nerally comparable over the course of infection between C57BL/6 and B-cell-
deficient mice, (iii) between 28 and 250 days after infection, cells from B
-cell-deficient mice reactivated gamma HV68 10- to 100-fold more efficientl
y than cells from C57BL/6 mice, (iv) at 7 weeks postinfection, B-cell-defic
ient mice had more genome-positive peritoneal cells than C57BL/6 mice, and
(v) mixing cells (ratio of 3 to 1) that reactivated inefficiently with tell
s that reactivated efficiently did not significantly decrease reactivation
efficiency. Consistent with a failure to normally regulate chronic gamma HV
68 infection, the majority of infected B-cell-deficient mice died between 1
00 and 200 days postinfection. We conclude that (i) B cells are not require
d for establishment of gamma HV68 latency, (ii) there are organ-specific di
fferences in the efficiency of gamma HV68 reactivation, (iii) B cells play
a crucial role in regulating reactivation of gamma HV68 from latency, and (
iv) B cells are important for controlling chronic gamma HV68 infection.